OMEN Pharma

Exposed: Massive Counterfeit Drug Ring Busted in Telangana – What They Were Making Will Shock You!

by

First Case Under Bharatiya Nyaya Sanhita, 2023 Targets Illegal Drug Manufacturing in Telangana In a significant crackdown on counterfeit drug manufacturing, Telangana’s Pet Basheerabad Police Station has registered the first case under the Bharatiya Nyaya Sanhita, 2023 against an illegal drug manufacturer. The offender, operating clandestinely in Medchal-Malkajgiri district, was found producing counterfeit versions of … Read more

PDMA Organizes Seminar on Revised Schedule M to Boost Drug Manufacturing Standards in Pondicherry

by

In response to recent closures affecting 36% of inspected drug manufacturing units nationwide due to non-compliance with Revised Schedule M standards, the Pondicherry Drug Manufacturers Association (PDMA) is set to host a seminar aimed at educating industry stakeholders on the updated Good Manufacturing Practices (GMP). Scheduled for July 13 in the union territory, the seminar … Read more

Roche’s Tiragolumab Combination Falls Short in First-Line Lung Cancer Study

by

Roche has reported that the phase II/III SKYSCRAPER-06 study, investigating tiragolumab in combination with Tecentriq (atezolizumab) and chemotherapy as a first-line treatment for previously untreated, locally advanced unresectable or metastatic non-squamous non-small cell lung cancer, did not achieve its primary endpoints in its initial analysis. The study did not demonstrate statistically significant improvements in progression-free … Read more

Pharma and Healthcare Leaders Urge Budget Focus on Innovation and Accessibility

by

Budget 2024-25: Pharma, Healthcare Leaders Call for Strategic Investments and Policy Reforms As India gears up for the Union Budget 2024-25, leaders from the pharmaceutical and healthcare sectors are advocating for strategic investments, policy reforms, and incentives to bolster innovation and accessibility in healthcare. The Indian Pharmaceutical Alliance (IP Alliance), Metropolis Healthcare, Alyve Health, and … Read more

Indian Pharmaceutical Congress (IPC) Highlights Industry’s Innovation and Collaboration Efforts

by

Indian pharmaceutical companies regularly leverage events like the Indian Pharmaceutical Congress (IPC) to showcase their latest advancements in drug development, technology integration, and adherence to global quality standards. Industry leaders emphasize that IPC serves as a crucial platform for demonstrating India’s capabilities in innovation and its significant contributions to global healthcare through affordable medicines and … Read more

Mobile Phone Data Unveils Pathogen Spread Insights, Raising New Vaccine Strategy Hopes

by

Researchers Use Mobile Phone Data to Track Pathogen Spread and Evolution In a groundbreaking study published in Nature, scientists have unveiled a novel approach to tracking the spread and evolution of pathogens like Streptococcus pneumoniae (pneumococcus), which are responsible for pneumonia, meningitis, and sepsis worldwide. This innovative method harnesses anonymised mobile phone data to map … Read more

Medigene has been granted a Chinese patent for their targeted T cell receptor that specifically targets the NY-ESO-1/LAGE 1a protein

by

Medigene AG, a company specializing in immuno-oncology, has received a patent from the Chinese Patent Office for its T cell receptor (TCR) targeting NY-ESO-1 and LAGE 1a. These antigens are known to be associated with various types of solid tumors and have been extensively studied and validated. The patent protects Medigene’s innovative approach to developing … Read more

Telangana Proposes Pharma University at Indian Pharmaceutical Congress 73rd Edition

by

Indian Pharmaceutical Congress 73rd Edition Advocates Strengthening Pharma Education and Digital Innovation The ongoing Indian Pharmaceutical Congress (IPC) in Hyderabad has highlighted the critical need to bolster pharmaceutical education as a cornerstone for advancing manufacturing capabilities, pioneering R&D programs, and integrating digital technologies. At the forefront of discussions is the proposal to establish a Pharma … Read more

GSK and CureVac Forge New Alliance to Accelerate mRNA Vaccine Development

by

GSK and CureVac Restructure Partnership for mRNA Vaccine Development GSK plc (LSE/NYSE: GSK) and CureVac N.V. (Nasdaq: CVAC) have announced a major restructure of their collaboration, shifting to a new licensing agreement aimed at optimizing investment and focusing on mRNA vaccine development. Since 2020, GSK and CureVac have collaborated on mRNA vaccines targeting infectious diseases. … Read more

Study Urges Enhanced Collaboration Between NIPERs and Industry to Drive Innovation and Self-Reliance

by

Study Urges Enhanced Academia-Industry Collaboration at NIPERs to Foster Self-Reliance A recent study conducted by the Entrepreneurship Development Institute of India, commissioned by the Department of Pharmaceuticals, underscores the critical need for National Institutes of Pharmaceutical Education and Research (NIPERs) to bolster multidisciplinary research efforts. According to the study, titled “Bridging academia-industry gap to achieve … Read more